Trial intelligence / Profile preview

Donepezil for persistent executive function deficit after traumatic brain injury

IRCT20130416013027N4Phase 2Completed

Sponsor
Guilan University of Medical Sciences
Start
Aug 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of donepezil in traumatic brain injury (TBI), sponsored by Guilan University of Medical Sciences. Primary endpoints: Cognitive dimensions and speed of information processing and executive functions, Stop Signal executive function test and 4 more. Started Aug 2020; status: completed.

02

Drugs

donepezil
03

Conditions

traumatic brain injury (TBI)

Beyond the preview

Go deeper on IRCT20130416013027N4.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20130416013027N4.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call